Inovio Investors Get Derivative Deal OK'd Over Vaccine Claims

By Emilie Ruscoe · June 15, 2023, 9:12 PM EDT

Investors in biotechnology firm Inovio Pharmaceuticals Inc. have received an initial green light from a Philadelphia federal judge for their agreement to settle their derivative action against the company's brass over...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

BEHESHTI v. KIM et al

Case Number

2:20-cv-01962

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Securities/Commodities

Date Filed

April 20, 2020